TY - JOUR PY - 2018// TI - Efficacy of electroconvulsive therapy in various psychiatric disorders: A hospital based longitudinal follow-up study JO - Journal of clinical and diagnostic research A1 - Kawoos, Y. A1 - Shah, I.A. A1 - Rather, Y.H. A1 - Wani, Z.A. A1 - Zarger, W.A. SP - VC10 EP - VC14 VL - 12 IS - 4 N2 - INTRODUCTION: Electroconvulsive Therapy (ECT) is one of the neurobiological therapies available for the treatment of various psychiatric disorders especially those resistant to pharmacotherapy or, where a rapid response is needed.

AIM: To study the response of patients with different psychiatric disorders to ECT and study the relationship between seizure duration and response.

MATERIALS AND METHODS: It was a longitudinal study where a total of 40 patients were studied. Patients aged ≥12 years, who were resistant to pharmacotherapy or, having conditions where rapid response was warranted like suicidality or catatonia were included in our study as cases. A written informed consent was taken from all patients or their caretakers wherever necessary. Scales for assessment of various disorders were applied before and after treatment.

RESULTS: Majority of the patients 37.5% were in the age-group of 38-47 years followed by 22.5% in 28-37 years. Only 5% of patients were aged >60 years. Males were slightly higher in number as compared to females (21:19). Affective disorders formed the major group of the patients (75%) followed by schizophrenia (10%), obsessive compulsive disorder (10%) and mental retardation (5%). Overall, 75% of patients showed >50% response to ECT with maximum response seen in affective disorders. No significant relation was seen between seizure duration and response to ECT.

CONCLUSION: ECT is very effective for treating various psychiatric disorders especially affective disorders. ECT is life saving in conditions like catatonia and suicidality. © 2018, Journal of Clinical and Diagnostic Research. All rights reserved.

Language: en

LA - en SN - 2249-782X UR - http://dx.doi.org/10.7860/JCDR/2018/31410.11446 ID - ref1 ER -